10,000 results
·
43ms
·
Sources: EU EUDAMED, US FDA
Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
FDA Pre-Market Approval
FDA Class 3
·ELECSYS ANTI-HBC IMMUNOASSAY ON ELECSYS 2010
Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·ELECSYS ANTI-HCV ON COBAS E 601
Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·ELECSYS ANTI-HCV ON MODULAR ANALYTICS E170
Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented
FDA Pre-Market Approval
FDA Class 3
·DURALOC OPTION CERAMIC ON CERAMIC HIP SYSTEM
Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
FDA Pre-Market Approval
FDA Class 3
·ELECSYS ANTI-HBC ON MODULAR ANALYTICS E170
Stent, Coronary
FDA Pre-Market Approval
FDA Class 3
·NIRxcell CoCr Coronary Stent on RX System
Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
FDA Pre-Market Approval
FDA Class 3
·ELECSYS ANTI-HBC ON COBAS E 601
Stent, Coronary
FDA Pre-Market Approval
FDA Class 3
·NIRxcell CoCr Coronary Stent on RX System
Stent, Coronary
FDA Pre-Market Approval
FDA Class 3
·NIRxcell CoCr Coronary Stent on RX System
Stent, Coronary
FDA Pre-Market Approval
FDA Class 3
·NIRXCELL COCR CORONARY STENT ON RX SYSTEM
Kit, Test, Alpha-Fetoprotein For Neural Tube Defects
FDA Pre-Market Approval
FDA Class 3
·ACCESS AFP ON THE ACCESS IMMUNOASSAY SYSTEMS
Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented
FDA Pre-Market Approval
FDA Class 3
·DURALOC OPTION CERAMIC ON CERAMIC HIP SYSTEM
Stent, Coronary
FDA Pre-Market Approval
FDA Class 3
·NIRxcell CoCr Cornary Stent on RX System
Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented
FDA Pre-Market Approval
FDA Class 3
·DURALOC OPTION CERAMIC-ON-CERAMIC HIP SYSTEM
Stent, Coronary
FDA Pre-Market Approval
FDA Class 3
·NIRxcell CoCr Coronary Stent on RX System
Stent, Coronary
FDA Pre-Market Approval
FDA Class 3
·NIRXCELL COCR-CORONARY STENT ON RX SYSTEM
Stent, Coronary
FDA Pre-Market Approval
FDA Class 3
·Nirxcell CoCr Coronary Stent on RX System
Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·ELECSYS ANTI-HCV ON COBAS E 411
Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
FDA Pre-Market Approval
FDA Class 3
·ELECSYS ANTI-HBC ON MODULAR ANALYTICS E170
Stent, Coronary
FDA Pre-Market Approval
FDA Class 3
·NIRXCELL COCR CORONARY STENT ON RX SYSTEM